Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Anoro Ellipta (umeclidinium/vilanterol)
pCPA File Number:
20841
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Obstructive Pulmonary Disease
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
SR0371-000
pCPA Engagement Letter Issued:
2015-02-04
Negotiation Process Concluded:
2015-05-01